Table 3.
Growth Factors | Group 1 | Group 2 | Group 3 | P |
---|---|---|---|---|
TGF-β (µg/ml) | Min-Max Mean ± SD |
|||
Before procedure | 26.8–152.4 | 22.7–81.4 | 16.4–108.3 | NS |
55.7 ± 43.6 | 38.4 ± 18.3 | 42.5 ± 22.9 | ||
Day 1 | 20.7–35.6 | 22.1–80.5 | 24.5–403.2 | <.05 |
26.9 ± 4.4 | 38.4 ± 18.4 | 84.9 ± 48.9 | ||
Day 4 | 24.5–33.5 | 21.5–79.7 | 25.9–272.1 | <.05 |
28.5 ± 3.2 | 37.2 ± 17.9 | 86 ± 81.5 | ||
Day 7 | 24.8–32.6 | 21.5–80.1 | 15.7–281.4 | <.05 |
29 ± 2.6 | 38.2 ± 11.9 | 89.2 ± 88.9 | ||
VEGF (pg/ml) | ||||
Before procedure | 1306–3813 | 1150–3796 | 1496–3528 | NS |
2797 ± 716.1 | 2263 ± 999.4 | 2842 ± 660.2 | ||
Day 1 | 1576–3748 | 1470–3788 | 2024–4679 | P < .05 |
2703 ± 685.9 | 2270 ± 1006.9 | 3222 ± 1048 | ||
Day 4 | 1254–3625 | 1204–3958 | 2170–5124 | P < .05 |
2524 ± 787.3 | 2373 ± 938.5 | 3138 ± 963.5 | ||
Day 7 | 1514–3152 | 1100–3854 | 1506.4–5241.6 | P < .05 |
2300 ± 560.2 | 2314 ± 892.9 | 3333 ± 1060 | ||
KGF (ng/ml) | ||||
Before procedure | 138.3–172.3 | 101.1–591.2 | 130.4–473.9 | NS |
155.1 ± 11 | 194.8 ± 140.6 | 218.4 ± 111.7 | ||
Day 1 | 142.8–182.4 | 111.5–595.3 | 106.5–584.6 | NS |
161.8 ± 11.8 | 196.8 ± 141.7 | 216 ± 147.2 | ||
Day 4 | 147.4–180.5 | 107.5–497 | 132.6–397.6 | NS |
165.7 ± 9.9 | 197.2 ± 141.6 | 206.1 ± 81.5 | ||
Day 7 | 149–178.5 | 111.4–597.9 | 157.7–502.2 | P < .05 |
164.8 ± 9 | 196.2 ± 142 | 228.2 ± 73.4 | ||
NGF (ng/ml) | ||||
Before procedure | 1.3–65 | 0.2–20.4 | 1.2–15.4 | NS |
12.2 ± 19.1 | 8.5 ± 12.4 | 5.8 ± 5.4 | ||
Day 1 | 0.6–15.8 | 0.1–22.5 | 0.1–21.1 | NS |
7.5 ± 5.2 | 8.4 ± 12 | 6.7 ± 6.6 | ||
Day 4 | 2–16.3 | 1–20.5 | 2.1–16.8 | NS |
7.7 ± 5.3 | 8.3 ± 9.6 | 12.1 ± 5.5 | ||
Day 7 | 1.5–15.5 | 0.9–17.1 | 2.1–24.6 | P < .05 |
7.8 ± 4.8 | 8.4 ± 12.3 | 13.7 ± 6.7 |
P-values following comparison between control groups (Group1 and Group-2) and the study group (Group-3). All values are given as minimum, maximum and mean, NS: not significant, SD: standart deviation.